FDA Approves New Non-Opioid Painkiller, Journavx: 'No Addiction Potential'
A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous ...
Roll Call21d
FDA publishes long-awaited front-of-package labeling proposal
FDA Commissioner Robert M ... Bernie Sanders, I-Vt., who then was chairman of the Committee on Health, Education, Labor and Pensions, slammed Califf last month, asserting that the agency was ...
Hosted on MSN15d
FDA approves Zydus’ Phase IIb trial of Usnoflast for ALS treatment
Zydus Lifesciences chairman Pankaj Patel said ... The company has also secured orphan drug status for the therapy from the FDA for treating Cryopyrin Associated Periodic Syndrome (CAPS).
JD Supra10h
RFK Jr.'s 2 Days in the Spotlight: Food Additives, Vaccines and Clinical Trials
Although Robert F. Kennedy Jr.'s nomination hearings to be the Secretary of the U.S. Department of Health and Human Services (HHS) focused on ...
TTUHSC Psychiatry chairman discusses newly approved antidepressant nasal spray
The FDA approved Spravato for those battling depression and has seen little to no improvement from two types of ...